Identification of tumor-suppressive miRNAs that target amino acid transporter LAT1 and exhibit anti-proliferative effects on cholangiocarcinoma cells
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Decreased tumor-suppressive miRNAs, miR-194-5p and miR-122-5p, contribute to LAT1 upregulation and cholangiocarcinoma (CHOL) cell proliferation. Restoring these miRNAs may offer novel cancer therapeutics.
Area Of Science
- Molecular Biology
- Cancer Research
- Biochemistry
Background
- Amino acid transporter LAT1 is upregulated in cholangiocarcinoma (CHOL), promoting cancer cell proliferation and progression.
- The molecular mechanisms behind LAT1's pathological upregulation in CHOL are not fully understood.
- MicroRNAs (miRNAs) are potential regulators of gene expression implicated in various cancers.
Purpose Of The Study
- To investigate the role of miRNA-mediated regulation in LAT1 expression in CHOL cells.
- To identify specific miRNAs that target and downregulate LAT1.
- To explore the therapeutic potential of targeting LAT1-regulating miRNAs in CHOL.
Main Methods
- Bioinformatic analysis to predict miRNAs targeting LAT1.
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to measure miRNA and LAT1 mRNA expression in CHOL tissues.
- Luciferase reporter assay to confirm direct targeting of LAT1 3'UTR by miRNAs.
- Transfection of miRNA mimics to assess the functional impact on LAT1 expression and cell proliferation.
Main Results
- Five candidate miRNAs predicted to target LAT1 were identified; miR-194-5p, miR-122-5p, and miR-126-3p were significantly downregulated in CHOL.
- Correlation analysis showed negative correlations between these miRNAs and LAT1 mRNA levels in CHOL tissues.
- miR-194-5p and miR-122-5p were confirmed to directly target LAT1 3'UTR.
- Transfection with miR-194-5p and miR-122-5p mimics suppressed LAT1 expression and inhibited CHOL cell proliferation.
Conclusions
- Downregulation of tumor-suppressive miRNAs (miR-194-5p, miR-122-5p) contributes to LAT1 upregulation in CHOL.
- This miRNA-LAT1 axis plays a role in CHOL cell proliferation.
- These miRNAs represent potential therapeutic targets for CHOL treatment and diagnostics.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...